Skip to content

Lucy Diane Mastrandrea, MD, PH

NPI 1760565105ActiveIndividual· Pediatrics, Pediatric Endocrinology· Buffalo, NY

Pediatrics, Pediatric Endocrinology (MD, PH) in Buffalo, New York, licensed in NY, with an NPI issued in October 2006. Part D covered 14 prescriptions written in 2024, 86% of them generic. Biomarin Pharmaceutical Inc. was the largest of 4 companies reporting payments in 2025, $641.77 in all, mostly food and beverage.

Overview

NPI1760565105
StatusActive
Entity typeIndividual
CredentialMD, PH
Sole proprietorNo
NPI issuedOct 21, 2006
Last updated in NPPESJan 18, 2021
Certified by providerJan 18, 2021

Specialties and licenses

TaxonomyCodeLicenseState
Pediatrics, Pediatric Endocrinology Primary2080P0205X223316NY

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Endocrinology (NY)

Part D prescriptions in 2024

Prescriptions (claims)14 · 24 30-day fills
Total drug cost$357.43
Generic share86% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$641.77 · 5 payments from 4 companies
  • 2024$397.98 · 5 payments from 4 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$641.77 · 5 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Pediatrics, Pediatric Endocrinology providers in Buffalo

All Pediatrics, Pediatric Endocrinology providers in New York